Under the proposal, food manufacturers would have to notify the Food and Drug Administration (FDA) before introducing new ingredients through the “generally recognized as safe” (GRAS) pathway.
Galderma (SIX: GALD) today announced that Restylane Shaype has been approved in the EU under the Medical Device Regulation for temporary augmentation of the chin region. Engineered for deep injection ...
The proposal would change a decades-old policy that advocates have called a regulatory loophole, blaming it for allowing ...
Europe is rearming, Russia is threatening, and faith in the defensive protection given by the United States is wavering. Even ...